Clinical Trials

NSCLC

NCT03893539 2024-03-29

Clinical Utility for Ion Endoluminal System

365 enrolled

Lung Diseases, Lung Neoplasms

NCT04209868 2024-03-29

ParaSOL

Phase 2/3 Unknown

100 enrolled

Thoracic Neoplasms

NCT06231680 2024-03-29

Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)

132 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms

NCT06286592 2024-03-29

LUNGevity: Lung Cancer Stigma Community Based Participatory Research

100 enrolled

Lung Neoplasms, Neoplasms, Smoking Cessation

NCT06334757 2024-03-28

Serplulimab Plus Bevacizumab and Chemotherapy for EGFR-mutant Metastatic NSCLC Patients After EGFR-TKI Treatment Failure

46 enrolled

Non-Squamous Non-Small Cell Lung Cancer

NCT06332287 2024-03-27

A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Advanced NSCLC With Leptomeningeal Metastasis

25 enrolled

Phase EARLY_PHASE1 Unknown

NSCLC

NCT06106152 2024-03-26

WTX212A Monotherapy and in Combination With PD -1/PD-L1 Monoclonal Antibody

20 enrolled

Advanced Lung Cancer

NCT06331650 2024-03-26

A Single-arm Pilot Study of First-line Treatment With Carbognilumab Combined With Chemotherapy in Patients With STK11-mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer

Phase EARLY_PHASE1 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02619448 2024-03-25

Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

12 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06195189 2024-03-25

WU-KONG36

Phase 1/2 Unknown

40 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06328049 2024-03-25

A Study of Trilaciclib Combined With Chemotherapy in the Treatment of NSCLC

NSCLC

NCT03322072 2024-03-20

GPS

28 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05649046 2024-03-18

PREVALUNG*

160 enrolled

Lung Neoplasms, Bronchitis, Chronic, Plaque, Atherosclerotic

NCT04903873 2024-03-15

A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors

Phase 1/2 Unknown

110 enrolled

GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Prostatic Neoplasms

NCT05801133 2024-03-15

Pifenidone Prophylactic Therapy for Radiation Lung Injury in Patients Who Have Previously Received Immune Checkpoint Inhibitors

41 enrolled

Lung Neoplasms

NCT05004974 2024-03-12

Sintilimab With Pemigatinib in Patients With PD-L1-positive and FGFR Mutated Advanced Non-small Cell Lung Cancer

20 enrolled

Advanced Non Small Cell Lung Cancer

NCT05872867 2024-03-12

MK-3475-E90

GastrointestinalHead & NeckThoracic

54 enrolled

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT06307093 2024-03-12

Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms

DermatologicHead & NeckThoracic

90 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Lung Neoplasms, Melanoma, Neoplasms

NCT06277674 2024-03-08

Efficacy of Cadonilimab in Non-squamous Non-small Cell Lung Cancer Patients Resistant to EGFR-TKI

20 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04544748 2024-03-06

A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies

DermatologicGenitourinaryThoracic

48 enrolled

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Neoplasms by Histologic Type, Urologic Neoplasms

NCT06293833 2024-03-05

ZORALCS

700 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Smoking Cessation, Small Cell Lung Carcinoma

NCT03865511 2024-02-28

MELROSE

150 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06279754 2024-02-28

Recombinant Human Endostatin Combined With Envafolimab and Synchronal Radiochemotherapy

Locally Advanced Squamous Non-small Cell Lung Cancer

NCT06281860 2024-02-28

PITHAC

BreastGastrointestinalGynecologicOther solid neoplasmThoracic

39 enrolled

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT03924466 2024-02-16

VUBAR

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

55 enrolled

Biliary Tract Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT06262555 2024-02-16

Novel Light Delivery Method for Performing Transbronchial Photodynamic Therapy for Peripheral Lung Cancer

3 enrolled

Lung Neoplasms

NCT06258954 2024-02-14

Effect of 3D-printed Reconstruction System in Size of Left DLT

200 enrolled

Lung Neoplasms

NCT05829057 2024-02-13

The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1

GastrointestinalGenitourinaryGynecologicThoracic

10 enrolled

Urinary Bladder Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Neoplasms, Ovarian Neoplasms, Small Cell Lung Carcinoma

NCT03274479 2024-02-09

PBF-1129 in Patients With NSCLC

18 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05602259 2024-02-09

PROTEON

200 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06234735 2024-02-09

RETOS

40 enrolled

Fatigue, Lung Neoplasms, Motor Activity, Sedentary Behavior

NCT01871454 2024-02-07

Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung Cancers

59 enrolled

Non-small Cell Lung Cancers

NCT05739695 2024-02-06

A Trial of Radial EBUS Versus VBN for the Peripheral Pulmonary Lesions

300 enrolled